Review
. 2006 Aug;32(9).
doi: 10.1016/j.ejso.2006.06.009.

Magnetic resonance imaging in breast cancer

M Van Goethem 1 W Tjalma  K Schelfout  I Verslegers  I Biltjes  P Parizel  
Affiliations
  • PMID: 16920327
  •     19 citations

Abstract

Aim: Due to its high sensitivity, magnetic resonance (MR) mammography is increasingly used as adjunct to mammography and ultrasound. The technique, however, has a relatively limited specificity. Therefore, it may only be used for specific indications. One of the indications is preoperative staging of breast carcinoma. This review serves to give an overview of the studies published on the role of MR in preoperative local staging.

Methods: We reviewed studies of the role of MR mammography in the detection of breast carcinomas and in the assessment of the diameter and extent of carcinomas. We also reviewed published studies on detection of multifocal and multicentric carcinomas that were occult on mammography and ultrasound. Advantages and drawbacks of preoperative MR mammography and the effect on treatment, as reported in different published studies, are described. The review is based on a search of PubMed, using specific terms for the different topics.

Results: MR has the highest sensitivity to detect invasive carcinomas and is best in assessment of tumor extent, including detection of multifocal, multicentric and bilateral disease.

Conclusion: MR mammography is a valuable adjunct to conventional imaging in the preoperative local staging of breast cancer.

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions.
J Veltman, M Stoutjesdijk, +4 authors, C Boetes.
Eur Radiol, 2008 Feb 14; 18(6). PMID: 18270714    Free PMC article.
Breast MRI: guidelines from the European Society of Breast Imaging.
R M Mann, C K Kuhl, K Kinkel, C Boetes.
Eur Radiol, 2008 Apr 05; 18(7). PMID: 18389253    Free PMC article.
Highly Cited.
Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy.
Sachiko Yuen, Takayoshi Uematsu, +2 authors, Tsunehiko Nishimura.
Eur Radiol, 2008 May 21; 18(10). PMID: 18491098
Combined PET/MRI: a new dimension in whole-body oncology imaging?
Gerald Antoch, Andreas Bockisch.
Eur J Nucl Med Mol Imaging, 2008 Dec 24; 36 Suppl 1. PMID: 19104802
Review.
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.
T A Heusner, S Hahn, +7 authors, G Antoch.
Br J Radiol, 2010 Oct 21; 84(998). PMID: 20959375    Free PMC article.
Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.
Xin Chen, Wen-ling Li, +3 authors, Zhi-lan Bai.
BMC Cancer, 2010 Dec 30; 10. PMID: 21189150    Free PMC article.
Whole-body hybrid PET/MRI: ready for clinical use?
Osman Ratib, Thomas Beyer.
Eur J Nucl Med Mol Imaging, 2011 Apr 06; 38(6). PMID: 21465254
A decade of change: an institutional experience with breast surgery in 1995 and 2005.
Amber A Guth, Beth Ann Shanker, +7 authors, Joan F Cangiarella.
Breast Cancer (Auckl), 2008 Jan 01; 1. PMID: 21655372    Free PMC article.
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
Wei Huang, Luminita A Tudorica, +8 authors, Charles S Springer.
Radiology, 2011 Aug 11; 261(2). PMID: 21828189    Free PMC article.
Incremental value of magnetic resonance imaging for breast surgery planning.
Sibel Ozkan Gurdal, Beyza Ozcinar, +7 authors, Mahmut Muslumanoglu.
Surg Today, 2012 Feb 02; 43(1). PMID: 22294425
Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up.
Anikó Sztrókay, Julia Herzen, +10 authors, Fabian Bamberg.
Eur Radiol, 2012 Aug 31; 23(2). PMID: 22932738
Review.
PET/MR: a paradigm shift.
Florian C Gaertner, Sebastian Fürst, Markus Schwaiger.
Cancer Imaging, 2013 Mar 01; 13. PMID: 23446110    Free PMC article.
Review.
Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study.
Virginia Gonzalez, Kerstin Sandelin, +5 authors, Brita Arver.
World J Surg, 2014 May 13; 38(7). PMID: 24817517
The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI.
Marc B I Lobbes, Ulrich C Lalji, +6 authors, Regina G Beets-Tan.
J Cancer, 2015 Jan 07; 6(2). PMID: 25561979    Free PMC article.
Limitations of mammography in the diagnosis of breast diseases compared with ultrasonography: a single-center retrospective analysis of 274 cases.
Hong Zhao, Liwei Zou, Xiaoping Geng, Suisheng Zheng.
Eur J Med Res, 2015 Apr 22; 20. PMID: 25896757    Free PMC article.
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.
Mohamed I Nounou, Fatema ElAmrawy, +3 authors, Hussaini Syed-Sha-Qhattal.
Breast Cancer (Auckl), 2015 Oct 16; 9(Suppl 2). PMID: 26462242    Free PMC article.
Review.
Autoantibodies as Potential Biomarkers in Breast Cancer.
Jingyi Qiu, Bailey Keyser, Zuan-Tao Lin, Tianfu Wu.
Biosensors (Basel), 2018 Jul 18; 8(3). PMID: 30011807    Free PMC article.
Review.
Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Patients with Invasive Lobular Carcinoma.
Jiyoung Yoon, Eun Kyung Kim, +3 authors, Vivian Y Park.
Korean J Radiol, 2020 Jul 18; 21(8). PMID: 32677379    Free PMC article.
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay.
Michael A Jacobs, Christopher B Umbricht, +5 authors, Antonio C Wolff.
Cancers (Basel), 2020 Oct 01; 12(10). PMID: 32992569    Free PMC article.